Search

everythinglearnresearchcommunity

for

Search:↓

Hair proteins have weak spots in their α-helical segments.

Outside factors like grooming, chemicals, and the environment can damage hair and cause disorders.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

Teprotumumab for thyroid eye disease commonly causes fatigue, brittle nails, dry eyes, hair loss, muscle spasms, and dry mouth, with rare serious events like blood clots.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Hair loss in Lichen Planopilaris is caused by immune system issues damaging hair follicles and stem cells.

Keratins are crucial for cell stability, wound healing, and cancer diagnosis.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Using neurohormones to control keratin can lead to new skin disease treatments.

Changing light exposure can affect hair growth timing in goats, possibly due to a key gene, CSDC2.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

The conclusion is that skin and hair patterns are formed by a mix of cell activities, molecular signals, and environmental factors.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

The document concludes that diagnosing and managing plaque psoriasis, particularly in sensitive areas, is challenging and requires careful differentiation from similar skin conditions.

COVID-19 and its vaccines can cause various skin issues due to viral effects, immune responses, and stress.